Veramorph Materials landed a spot in a Delaware business accelerator backed by DuPont to develop its hydrogel-based oral drug delivery platform. Veramorph and MCET Technologies (which is developing wearable sensor technology) won their spots in the Delaware Innovation Space via the DuPont FastPass competition. The companies get a year of free access to the accelerator, […]
Livongo share prices double after upsized $356m IPO
Investors added nearly 50% to the share price for Livongo Health (NSDQ:LVGO) today after it raised $355 million with its initial public offering after a last-minute upsizing. The Mountain View, Calif.-based company, which developed a digital health platform to manage chronic diseases, said earlier this week that it planned to float 10.7 million shares at $24 […]
Livongo boosts IPO to $268m midpoint
Livongo Health yesterday boosted the range on its pending initial public offering, saying the flotation would now fetch nearly $268 million at the midpoint. The Mountain View, Calif.-based company developed a digital health platform to manage chronic diseases, selecting diabetes as its first target. After a series of upsizing announcements, Livongo yesterday said it plans […]
Frequency Therapeutics inks $625m deal with Astellas, adds $62m Series C
Frequency Therapeutics said today that it raised a $62.0 million Series C round for the hearing loss drug it’s developing and inked a development and overseas distribution deal with Astellas Pharma that’s worth $625 million. Woburn, Mass.-based Frequency drew a $42 million Series B early this year; including the financing announced today, a $32 million […]
Senseonics prices $107m worth of stock, debt offerings
Senseonics (NYSE:SENS) today priced stock and debt offerings worth a total of at least $107 million. Germantown, Md.-based Senseonics, which developed the Eversense implantable CGM, announced the offerings yesterday. Today the company priced $82 million worth of 5.25% convertible senior notes due 2025. Part of the expected $77 million in net proceeds are earmarked for buying […]
Senseonics slides on stock, debt offerings, Q2 prelims
Senseonics (NYSE:SENS) shares are off nearly -7% today after the continuous glucose monitor maker revealed plans for a stock and debt offerings and released its preliminary second-quarter sales numbers. Germantown, Md.-based Senseonics, which developed the Eversense implantable CGM, said it plans to float $25 million in stock (plus a 30-day, $3.8 million underwriters option) and $80 […]
NovaBay raises $2.4m
NovaBay Pharmaceuticals (NYSE:NBY) said this week that it raised $2.4 million in an offering that included three investors. The Emeryville, Calif.-based company has developed products for the eye care market, including a prescription for managing hygiene of the eyelids and lashes. NovaBay’s Avenova is formulated with a pure form of hypochlorous acid and is designed to […]
AgaMatrix raises $56m for WaveForm CGM
AgaMatrix said today that it brought in a $56 million funding round for the eponymous continuous glucose monitor its WaveForm Technologies subsidiary is developing. The round, which includes $6 million from new and existing backers and $50 million in senior debt financing from Perceptive Advisors, is slated for paying down debt and increasing production capacity, […]
Livongo Health files for $100m IPO
Livongo Health last week filed for an initial public offering worth $100 million for the digital health platform it developed to treat chronic diseases. The Mountain View, Calif.-based company’s initial focus on diabetes involves a smart, cellular-connected glucose meter, automatically-delivered testing materials, real-time coaching and full-time monitoring. The system personalizes messages based on each glucose […]
Mercator MedSystems adds $3m
Mercator MedSystems said last week that it added more than $3 million to the $11 million Series D it pulled in last year.* The California-based company is developing catheter-guided micro-infusion systems for non-systemic delivery of therapeutic agents across blood vessels as a treatment for peripheral artery disease. In June of last year, Mercator MedSystems raised […]
- 1
- 2
- 3
- …
- 27
- Next Page »
Drug Delivery Business News
@DrugDeliveryNow
LinkedIn